Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

New treatments for hair loss are emerging, and doctors need to learn how to use them effectively.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Topical corticosteroids are the best initial treatment for children with Alopecia Areata.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

More effective treatments are needed for severe alopecia areata.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

A woman's hair grew back with baricitinib treatment, but she developed a temporary hairy tongue that was treated with regular tongue brushing.

Tofacitinib is effective and safe for treating alopecia areata.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Stress-related hair loss was reversed with a special medication.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

There is no cure for alopecia areata, but treatments like JAK inhibitors show promise.